Statistics

Total Visits

Views
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 288
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 77

Total Visits per Month

January 2024 February 2024 March 2024 April 2024 May 2024 June 2024 July 2024
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 10 3 7 10 25 48 6

File Downloads

Views

Top Country Views

Views
United States 152
Australia 68
China 20
France 19
Ireland 15
Singapore 14
Vietnam 10
Germany 9
Netherlands 9
Hong Kong SAR China 8

Top City Views

Views
Kaleen 40
Dublin 15
Ashburn 11
Boardman 11
Hanoi 10
Singapore 10
Rotterdam 8
Buffalo 6
Helsinki 5
Melbourne 5